Stock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition

Stock Track

Jun 01

4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.

The sharp price increase appears to be driven by two key developments. First, the company has scheduled a special call to present on the clinical use of its CT:VQ non-contrast post-processing technology, drawing fresh attention to how this lung imaging software might fit into everyday healthcare workflows. This comes as the company's CT:VQ technology is being described as the first non-invasive, contrast-free imaging technology for lung scanning.

Second, 4DMedical announced it has signed an agreement to acquire Contextflow to establish a European commercial and clinical platform. The acquisition terms include A$18.56 million in cash, 56,235 shares, and up to 2.59 million options, representing a strategic move to expand the company's presence in the European market through this acquisition.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1131606859"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131606859\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131606859?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 08:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131606859","market":"nz","top_or_hot":-1,"title":"Stock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition","media":"Stock Track","content":"<p>4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.</p><p>The sharp price increase appears to be driven by two key developments. First, the company has scheduled a special call to present on the clinical use of its CT:VQ non-contrast post-processing technology, drawing fresh attention to how this lung imaging software might fit into everyday healthcare workflows. This comes as the company's CT:VQ technology is being described as the first non-invasive, contrast-free imaging technology for lung scanning.</p><p>Second, 4DMedical announced it has signed an agreement to acquire Contextflow to establish a European commercial and clinical platform. The acquisition terms include A$18.56 million in cash, 56,235 shares, and up to 2.59 million options, representing a strategic move to expand the company's presence in the European market through this acquisition.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-01 08:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.</p><p>The sharp price increase appears to be driven by two key developments. First, the company has scheduled a special call to present on the clinical use of its CT:VQ non-contrast post-processing technology, drawing fresh attention to how this lung imaging software might fit into everyday healthcare workflows. This comes as the company's CT:VQ technology is being described as the first non-invasive, contrast-free imaging technology for lung scanning.</p><p>Second, 4DMedical announced it has signed an agreement to acquire Contextflow to establish a European commercial and clinical platform. The acquisition terms include A$18.56 million in cash, 56,235 shares, and up to 2.59 million options, representing a strategic move to expand the company's presence in the European market through this acquisition.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"4DX.AU","symbol_name":"4DMEDICAL LTD","start_time":0,"source_url":"","article_id":"1131606859","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131606859","pubTimestamp":1780272164,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp price increase...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"4DX.AU":"4DMEDICAL LTD"},"translate_title":"个股追踪|4DMedical盘中大涨5.79%CT：VQ Clinical通过收购Contextflow实现看涨期权和欧洲扩张","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"4DX.AU":1},"content_text":"4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp price increase appears to be driven by two key developments. First, the company has scheduled a special call to present on the clinical use of its CT:VQ non-contrast post-processing technology, drawing fresh attention to how this lung imaging software might fit into everyday healthcare workflows. This comes as the company's CT:VQ technology is being described as the first non-invasive, contrast-free imaging technology for lung scanning.Second, 4DMedical announced it has signed an agreement to acquire Contextflow to establish a European commercial and clinical platform. The acquisition terms include A$18.56 million in cash, 56,235 shares, and up to 2.59 million options, representing a strategic move to expand the company's presence in the European market through this acquisition.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}